Search by Drug Name or NDC
NDC 54859-0702-60 Conex 2; 60 mg/1; mg/1 Details
Conex 2; 60 mg/1; mg/1
Conex is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION. The primary component is DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Brompheniramine relieves red, irritated, itchy, watery eyes; sneezing; and runny nose caused by allergies, hay fever, and the common cold. Brompheniramine helps control symptoms, but does not treat the cause of the symptoms or speed recovery. Brompheniramine should not be used to cause sleepiness in children. Brompheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 54859-0702-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Brompheniramine
Product Information
NDC | 54859-0702 |
---|---|
Product ID | 54859-702_21a5aaa5-eb19-425d-b026-47efa1c04bdc |
Associated GPIs | 43993002540310 |
GCN Sequence Number | 001153 |
GCN Sequence Number Description | dexbrompheniramine/pseudoephed TABLET 2 MG-60 MG ORAL |
HIC3 | Z2N |
HIC3 Description | 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION |
GCN | 96446 |
HICL Sequence Number | 000507 |
HICL Sequence Number Description | DEXBROMPHENIRAMINE MALEATE/PSEUDOEPHEDRINE HCL |
Brand/Generic | Generic |
Proprietary Name | Conex |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Dexbrompheniramine Maleate, Pseudoephedrine HCl |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 2; 60 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Labeler Name | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 54859-0702-60 (54859070260)
NDC Package Code | 54859-702-60 |
---|---|
Billing NDC | 54859070260 |
Package | 60 TABLET in 1 BOTTLE (54859-702-60) |
Marketing Start Date | 2007-11-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 82f9f52c-797e-4842-9c9a-40213181d99a Details
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Uses
- Temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies
- helps decongest sinus openings and sinus passages
- Reduces swelling of nasal passages, shrinks swollen membranes, and temporarily restores freer breathing through the nose
- Temporarily alleviates the following symptoms due to hay fever (allergic rhinitis): runny nose, sneezing, itching of the nose or throat, itching and watery eyes.
SPL UNCLASSIFIED SECTION
Warnings:
Ask a doctor before you use if you are- taking sedatives or tranquilizers.
- heart disease
- high blood pressure
- thyroid disease
- diabetes
- glaucoma
- difficulty in urination due to the enlargement of the prostate gland.
- do not exceed the recommended dosage
- excitability may occur, especially in children
- drowsiness may occur
- avoid alcoholic beverages
- alcohol, sedatives and tranquilizers may increase drowsiness
- use caution when driving a motor vehicle or operating machinery
- nervousness, dizziness or sleepiness occur
- symptoms do not improve withing 7 days or occur with a fever
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Do not use if you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions
or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if you are taking a prescription drug that contains MAOI;
ask your doctor or pharmacist before taking this product.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Other Information: Store at controlled room temperature 20 - 25 degree celsius (68 - 77 degree fahrenheit); excursions permitted to
15 - 30 degree celsius ( 59 - 86 degree fahrenheit) [ See USP Controlled Room Temperature] Tamper evident by imprinted heat seal
under cap. Do not use if there is evidence of tampering.
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
CONEX
dexbrompheniramine maleate, pseudoephedrine hcl tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION (037342305) |
Registrant - LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION (037342305) |